Sage Journals: Discover world-class research

Abstract

Skin-cartilage composite grafts are invaluable tissues used in facial reconstruction, yet their survival is unpredictable beyond a 1-cm diameter. In this study, the angiogenic growth factors basic fibroblast growth factor (bFGF) and endothelial cell growth factor (ECGF) and a penetrance enhancer (dimethyl sulfoxide [DMSO]) were applied to composite grafts to determine their effects on survival and vascularization. We applied ECGF, bFGF, and DMSO either topically or by intradermal injection to 120 auricular composite grafts (3.0 cm diameter) in New Zealand White rabbits. Dermabrasion was performed in 2 groups to attempt to increase transdermal delivery. Graft viability and vascularity were evaluated 3 weeks later by template analysis and angiography. In the results, ECGF and bFGF, when grouped together, had a 40% increase in vascular ingrowth as compared to controls (p < .001). However, neither ECGF nor bFGF increased graft survival. A coincidental finding was that DMSO with dermabrasion significantly improved graft viability (>100%) with or without an angiogenic agent (p < .02). The potential of DMSO with dermabrasion to increase composite graft viability warrants further investigation.

Keywords

graft graft survival growth substance vascularization

Get full access to this article

View all access options for this article.

References

Brown

Cannon

. Composite free graft of skin and cartilage from ear. Surg Gynecol Obstet 1946; 82: 253–5.

MacCollum

Grabb

. Increasing the incidence and size of successful experimental composite ear grafts by advance preparation of the recipient bed. Plast Reconstr Surg 1977; 60: 759–62.

Hartman

Goode

. Pharmacologic enhancement of composite graft survival. Arch Otolaryngol Head Neck Surg 1987; 113: 720–3.

Aden

Biel

. The evaluation of pharmacologic agents on composite graft survival. Arch Otolaryngol Head Neck Surg 1992; 118: 175–8.

Henrich

Logan

Lewis

Shockley

. Composite graft survival. An auricular amputation model. Arch Otolaryngol Head Neck Surg 1995: 121: 1137–42.

Folkman

Klagsbrun

. Angiogenic factors. Science 1987; 235: 442–7.

Khouri

Brown

Leal-Khouri

Tark

Shaw

Centre

. The effect of basic fibroblast growth factor on the neovascularisation process: Skin flap survival and staged flap transfers. Br J Plast Surg 1991; 44: 585–8.

Hom

Assefa

. Effects of endothelial cell growth factor on vascular compromised skin flaps. Arch Otolaryngol Head Neck Surg 1992; 118: 624–8.

Baird

Walicke

. Fibroblast growth factors. Br Med Bull 1989; 45: 438–52.

10.

Cuevas

Burges

Baird

. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem Biophys Res Commun 1988; 156: 611–8.

11.

Chien

Liu

. Transdermal drug delivery systems. J Biomater Appl 1986; 1: 183–205.

12.

Kazim

Weber

Strausberg

La Foret

Reemtsma

. Effect of topical insulin on blood glucose of diabetic mice. Surg Forum 1984; 35: 64–6.

13.

Weber

Jicha

Matz

. Passage of somatostatin analogues across human and mouse skin. Surgery 1987: 102: 974–81.

14.

Sodicoff

Lamperti

Ziskin

. Transdermal absorption of radioprotectors using permeation-enhancing vehicles. Radiat Res 1990; 121: 212–9.

15.

Arden

Smith

Salley

Sakr

Doerr

. Survival of composite chondrocutaneous grafts by vessel implantation: A study in the rabbit ear model. Laryngoscope 1995; 105: 1326–33.

16.

Clairmont

Conley

. The uses and limitations of auricular composite grafts. J Otolaryngol 1978; 7: 249–56.

17.

Smith

Dickinson

Cipcic

. Composite grafts in facial reconstructive surgery. Arch Otolaryngol 1972; 95: 252–64.

18.

Rees

. The transfer of free composite grafts of skin and fat: A clinical study. Plast Reconstr Surg 1960; 25: 556–64.

19.

Ballantyne

Converse

. Vascularization of composite auricular grafts transplanted to the chorioallantois of the chick embryo. Transpl Bull 1958; 5: 373–7.

20.

Rees

Converse

Guy

. Composite grafts. Transactions of the Third International Congress of Plastic and Reconstructive Surgery, Washington, DC, 1963.

21.

Berti

Lipsky

. Transcutaneous drug delivery. Mayo Clin Proc 1995; 70: 581–6.

22.

Lebredo

Barrie

Woltering

. DMSO protects against Adriamycin-induced tissue necrosis. J Surg Res 1992; 53: 62–5.

Effects of Angiogenic Growth Factors and a Penetrance Enhancer on Composite Grafts

Abstract

Keywords

Get full access to this article

References